{"id":"NCT01765764","sponsor":"Allergan","briefTitle":"Bimatoprost for the Treatment of Eyebrow Hypotrichosis","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03-13","primaryCompletion":"2014-01-31","completion":"2014-02-11","firstPosted":"2013-01-10","resultsPosted":"2015-01-26","lastUpdate":"2019-04-23"},"enrollment":357,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Eyebrow Hypotrichosis"],"interventions":[{"type":"DRUG","name":"bimatoprost solution","otherNames":[]},{"type":"DRUG","name":"Vehicle to bimatoprost solution","otherNames":[]}],"arms":[{"label":"Bimatoprost Solution BID","type":"EXPERIMENTAL"},{"label":"Bimatoprost Solution QD","type":"EXPERIMENTAL"},{"label":"Vehicle to Bimatoprost Solution BID","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the safety and efficacy of bimatoprost solution compared with vehicle in the treatment of eyebrow hypotrichosis (inadequate eyebrows).","primaryOutcome":{"measure":"Percentage of Participants With at Least a 1-Grade Increase (Improvement) in the 4-Point Global Eyebrow Assessment (GEBA) Scale","timeFrame":"Baseline, Month 7","effectByArm":[{"arm":"Bimatoprost Solution BID","deltaMin":83.9,"sd":null},{"arm":"Bimatoprost Solution QD","deltaMin":77.1,"sd":null},{"arm":"Vehicle to Bimatoprost Solution BID","deltaMin":43,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":2},"locations":{"siteCount":2,"countries":["United States","Canada"]},"refs":{"pmids":["27124878"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":118},"commonTop":["Upper respiratory tract infection"]}}